PubMed
Acetyl hexapeptide-3 in a emulsion formulation for reduced wrinkle depth
Raikou et al., 2009
Acetyl Octapeptide-3
Topical cosmetic peptide used in anti-wrinkle formulations.
Trend index
Overview
Topical cosmetic peptide used in anti-wrinkle formulations.
Community
Positive 0% · Neutral 100% · Negative 0%
Median: 0–25 mcg · Most common: 0–25 mcg
Research
PubMed
Raikou et al., 2009
Help
This page summarizes 6 anonymized self-reports from PeptIQ users who track SNAP-8, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
1 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
This wiki does not assess safety or recommend use. SNAP-8 is listed as OTC Cosmetic. Consult a licensed clinician for personal medical decisions.
Research, primarily in animal models, suggests SNAP-8 may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.
SourceSNAP-8 is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified SNAP-8 as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.
SourceThe safety and effectiveness of SNAP-8 have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.
SourceWhile there are over 200 published studies on SNAP-8, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.
Source